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Background: Correct diagnosis is pivotal to understand and treat neurological disease. Herein, we report the
diagnostic work-up utilizing exome sequencing and the characterization of clinical features and brain MRI in
two siblings with a complex, adult-onset phenotype; including peripheral neuropathy, epilepsy, relapsing
encephalopathy, bilateral thalamic lesions, type 2 diabetes mellitus, cataract, pigmentary retinopathy and tremor.
Methods: We applied clinical and genealogical investigations, homozygosity mapping and exome sequencing to
establish the diagnosis and MRI to characterize the cerebral lesions.
Results: A recessive genetic defect was suspected in two siblings of healthy, but consanguineous parents.
Homozygosity mapping revealed three shared homozygous regions and exome sequencing, revealed a novel
homozygous c.367 G>A [p.Asp123Asn] mutation in the α-methylacyl-coA racemase (AMACR) gene in both patients.
The genetic diagnosis of α-methylacyl-coA racemase deficiency was confirmed by demonstrating markedly
increased pristanic acid levels in blood (169 μmol/L, normal <1.5 μmol/L). MRI studies showed characteristic
degeneration of cerebellar afferents and efferents, including the dentatothalamic tract and thalamic lesions in
both patients.
Conclusions: Metabolic diseases presenting late are diagnostically challenging. We show that appropriately applied,
homozygosity mapping and exome sequencing can be decisive for establishing diagnoses such as late onset
α-methylacyl-coA racemase deficiency, an autosomal recessive peroxisomal disorder with accumulation of pristanic
acid. Our study also highlights radiological features that may assist in diagnosis. Early diagnosis is important as
patients with this disorder may benefit from restricted dietary phytanic and pristanic acid intake.
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High-throughput sequence capture methods and next
generation sequencing (NGS) technologies make exome
sequencing an effective method to identify the cause of
Mendelian disorders [1-3]. Exome sequencing has primar-
ily been applied to identify novel genetic causes of disease
although it is increasingly being used in the diagnostic* Correspondence: laurence.bindoff@helse-bergen.no
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distribution, and reproduction in any mediumsetting, particular in disorders displaying locus heterogen-
eity such as ataxias, Charcot-Marie-Tooth disease (CMT),
hereditary spastic paraplegias (HSP) and retinitis pigmen-
tosa [3-5]. Large genes containing numerous mutations
may also be effectively screened by NGS. In addition, exo-
me sequencing may be an important tool for correctly
diagnosing rare disorders, [6] particularly when they ma-
nifest phenotypic heterogeneity.
We used exome sequencing to diagnose α-methylacyl-
coA racemase deficiency (MIM 614307), an autosomal
recessive peroxisomal disorder with accumulation oftral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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racemase deficiency has previously been reported in
eight adult patients worldwide and the disorder has
been associated with heterogeneous clinical presenta-
tions (Table 1) [7-14]. Peroxisomes are involved in the
breakdown of very-long-chain fatty acids (VLCFAs),
polyunsaturated fatty acids, and branched-chain fatty
acids like phytanic and pristanic acid. In addition, pe-
roxisomes are involved in the formation of primary
C24-bile acids by β-oxidation of the bile-acid intermedi-
ates di- and trihydroxycholestanoic acids (DHCA and
THCA) [15]. In peroxisomal disorders affecting break-
down of branched-chain fatty acids, phytanic acid and
pristanic acid accumulate [16]. Phytanic acid and pristanic
acid are degradation products from the chlorophyll side-
chain phytol. Both phytanic acid and pristanic acid are
derived directly from dietary sources such as meat and
dairy products from ruminants. Additionally, oils, fats and
milk derived from molluscs, fish and whales are important
sources of these fatty acids in humans [17]. Phytanic acid
is metabolized via peroxisomal α-oxidation to pristanic
acid. Pristanic acid undergoes β-oxidation in peroxisomes
with subsequent β-oxidation in mitochondria. Peroxi-
somal biogenesis disorders (PBD), e.g. Zellweger syn-
drome (MIM 214100), are characterized by defects in
both α- and β-oxidation. In contrast, single enzyme defi-
ciencies (SED) have either deficient α- or β-oxidation [18].
Peroxisomal SED include X-linked adrenoleukodystrophy
(MIM 300100) , Refsum disease (MIM 266500), α-methy-
lacyl-coA racemase (AMACR) deficiency (MIM 614307),
sterol carrier protein X (SCPx) deficiency (MIM 613724)
and D-bifunctional protein (DBP) deficiency (MIM 261515)
[9,15,19].
We report two siblings with a novel homozygous
missense mutation (c.367 G>A; [p.Asp123Asn]) in the
AMACR-gene. The diagnosis of α-methylacyl-coA race-
mase deficiency was made using exome sequencing and
confirmed by demonstrating markedly increased pristanic
acid levels in blood. Furthermore, we provide a detailed
description of the specific MRI findings in this disorder
(Figure 1). Our findings highlight the neuroanatomical
structures affected in α-methylacyl-coA racemase defi-
ciency and show that MRI has high diagnostic specificity
early in the course of the disease.
Methods
Samples
Two siblings of healthy, consanguineous parents with
similar clinical and radiological findings were examined
on several occasions during the course of their disease.
Our study was approved by the Regional Committee for
Medical and Health Research Ethics, Western Norway
(IRB00001872). All study participants provided written
informed consent.Ophthalmological investigation
Patient B underwent a thorough clinical ophthalmologi-
cal examination including determination of colour vision
by Farnsworth D15, visual field by Goldmann perimetry
and retinal thickness and structure by Optical coherence
tomography. Fullfield electroretinogram was recorded as
previously described [20]. Patient A had undergone sev-
eral ophthalmological examinations and his medical re-
cords were reviewed for this study.
Genetic studies
Genealogical data from the patients, local parish regis-
ters and population censuses were used. Whole genome,
single nucleotide polymorphism (SNP) genotyping was
performed utilizing the Genome-Wide Human SNP Array
6.0 (Affymetrix, Santa Clara, CA) and homozygosity map-
ping performed using the PLINK program [21]. Targeted
capture and exome sequencing were performed at
HudsonAlpha Institute for Biotechnology (Huntsville,
AL); Exome capture was performed using Roche-
NimbleGen Sequence Capture EZ Exome v2 kit and
paired-end 100nt sequencing on the Illumina HiSeq. The
paired-end reads were analyzed with Casava v1.8
(Illumina Inc) and aligned to the hg19 reference genome
using Burrows-Wheeler Alignment tool (BWA) [22]. This
resulted in 11.0 Giga-bases of aligned sequence data and
124X median coverage of the target capture regions. PCR
duplicates were removed with PICARD (http://picard.
sourceforge.net) and the Genome analysis toolkit (GATK)
was used for base quality recalibration [23]. SNPs and
indels were called by SAMtools using a minimum
threshold of 8X sequencing depth and quality score ≥ 30
[24]. Annovar was used for variant annotation [25].
Variant prioritization was performed based on a reces-
sive model, filtering against variants identified in
more than 80 Norwegian exome-resequencing samples
(obtained using the same whole exome sequencing
pipe-line) and variants present at >0.5% allele frequency in
the 1000 Genomes database (phase 1 project data
2010.08.04 sequence index, (26.1 million SNPs released
in November 2010 and 3.7 million indels released in
February 2011). Variants not in the CCDS or in puta-
tive splice sites (defined as 2 bps flanking coding
exons) and synonymous variants were also excluded.
Radiological investigations
Three brain MRI studies from patient A and nine from
patient B were available for investigation. The MRI scans
had been acquired over three and 11 years, respectively
and this sequential data allowed us to study lesion evo-
lution both during the chronic and acute phases of
the disease. Diffusion imaging was performed during
acute encephalopathy episodes. MRI was performed
on a Siemens Magnetom Symphony 1.5 T scanner with
Table 1 Clinical features in adult α-methylacyl-coA racemace deficiency patients
Pt 1 [9,11] Pt 2 [9] Pt 3 [7] Pt 4 [13] Pt 5 [12] Pt 6 [10] Pt 7 [8] Pt 8 [14] Pt A* Pt B*
Age of onset/
Gender
18/M 48/F 36/F 13/F 2nd decade/ M 3rd decade/ M 50/M 3nd decade/M 30/M 33/F
Presentation developmental
delay, episode
with blindness
spastic paraparesis tremor seizures seizures neuroleptic
malignant syndrome
with rhabdomyolysis
gait ataxia,
dysarthria
seizures arm weakness seizures
Seizures Yes No Yes Yes Yes Yes Yes Yes Yes Yes
Encephalopathic
episode(s)
Yes No Yes Yes Yes Yes No Yes Yes Yes
Tremor No No upper limbs,
head, voice
No No No No No No upper
limbs, head
Cerebellar No No dysarthria No No No gait ataxia,
dysarthria
No No No
Neuropathy sensory-motor sensory-motor No mild sensory mononeu-
ropathies
sensory axonal sensory-motor sensory-motor sensory-motor
Retinopathy RP N/A RP No RP degenera-tive
retino-pathy
N/A pigmentary
retinopathy
pigmentary
retinopathy
pigmentary
retinopathy
DM II N/A N/A N/A N/A N/A N/A N/A No Yes Yes
Additional
Features
primary
hypogonadism,
migraine
migraine cataract, migraine,
hyperreflexia
depression
cognitive decline,
unsteady gait,
depression
primary
hypogonadism
schizophrenia, decline in
short-term
memory
low
s-testosterone
cataract cataract
AMACR-gene
mutation
c.154 T>C
[p.Ser52Pro]
c.154 T>C
[p.Ser52Pro]
c.154 T>C
[p.Ser52Pro]
c.154 T>C
[p.Ser52Pro]
c.154 T>C
[p.Ser52Pro]
c.559 G>A
[p.Gly187Arg]
c.154 T>C
[p.Ser52Pro]
N/A c.367 G>A,
[p.Asp123Asn]
c.367 G>A,
[p.Asp123Asn]
Summary of reported clinical features in adult α-methylacyl-coA racemace deficiency patients. Pt=patient, RP=retinitis pigmentosa, DM II= type 2 diabetes mellitus.
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Figure 1 Chronic and acute brain MRI findings in α-methylacyl-coA racemace deficiency. A) Representative axial T2-images showing
different brainstem levels and the thalami in a caudocranial direction. There is evidence of chronic degeneration of both cerebellar efferent and
afferent pathways. A1) No evidence of inferior olivary lesion in the medulla oblongata. A2) High signal of the dentate nucleus (arrow). This
finding was preceded by loss of T2 hypointensity. High signal and atrophy of the pons is also apparent at this level. A3) High signal in the
superior cerebellar peduncle (SCP; arrow). In addition, there is degeneration of the cerebellar afferents with pontine atrophy and hyperintensity
corresponding to the transverse pontine fibers. A4) High signal corresponding to the decussation of SCP. A5) High signal corresponding to the
dentatothalamic tract (arrow) at the level of the inferior colliculus in the midbrain. A6) Probable loss of T2 hypointensity in the red nucleus
(arrow) on 3 Tesla MRI and high signal in the superior colliculus. A7) High signal in the posterior commissure (arrow). A8) High signal in the
thalami. B) Acute lesion two weeks into an encephalopatic episode with aphasia, right upper limb paresis, central facial palsy and reduced
consciousness in patient B. Left frontal high T2-signal cortical lesion (B1), showing a mixed diffusion pattern with areas of both high and low
apparent diffusion coefficient (ADC) (B2-B3).
Haugarvoll et al. Orphanet Journal of Rare Diseases 2013, 8:1 Page 4 of 10
http://www.ojrd.com/content/8/1/130 mT/m gradients or a General Electric Signa Excite
3 T HDX scanner with 40 mT/m gradients. Sequences
included T1, T2 and T2 fluid-attenuated inversion re-
covery. Diffusion imaging was performed with b values
of 0, 500 and 1000.
Measurement of blood pristanic acid level was perfor-
med using a standard diagnostic protocol.
Results
Clinical characteristics
Patient A
At age 30 years this man reported a feeling of weakness
in his upper limbs. Two years later he developed peri-
odic discomfort in his lower extremities. Subsequently,
he experienced fatigue following moderate physical ac-
tivity and episodic elevation of serum creatine kinase
(CK) and lactate dehydrogenase (LDH) were found. He
underwent a brief ophthalmic examination at the age of
37 at which time bilateral incipient cataracts were noted.
No retinal degeneration was described. At age 39 years,a demyelinating peripheral neuropathy was diagnosed
and a glucose tolerance test was consistent with type 2
diabetes mellitus. At this time, his liver enzymes were
mildly increased and ultrasound of the liver showed
steatosis. At age 48 years he developed an acute ence-
phalopathic episode with headache and profound bilat-
eral visual loss (no perception of light). Ophthalmoscopy
revealed normal optic discs with a bilateral pigmentary
retinopathy most pronounced in the mid-periphery but
also involving the macula. Visual evoked potential sug-
gested post-chiasmal damage. Thirteen days after onset
of the episode he developed complex partial seizures
with rotation of the head, repetitive hand movements in
his right upper limb and reduced conciseness. His visual
acuity gradually improved over the next year to 0.32
(Snellen) in both eyes. The lens opacities remained sta-
ble and cataract surgery was not indicated. At age 51 years
a liver tumor was diagnosed, biopsy showed probable
liver-sarcoma. He died within months and autopsy was
declined.
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The patient is the sister of patient A and she developed
her first symptoms age 33 years during pregnancy. At this
time she experienced several episodes of dysarthria com-
bined with numbness and impaired control in her left
arm, lasting for a few minutes. These were probably par-
tial seizures and she had two further episodes age 40, but
the diagnosis of epilepsy was not established until she was
49 years old and had several episodes of dysphasia, right
sided central facial palsy and upper right limb numbness.
Type 2 diabetes mellitus was diagnosed aged 48 years. In
her late forties she gradually developed upper limb tremor,
with both positional and intentional characteristics, and
later head tremor; the tremor is alcohol responsive. Per-
ipheral neuropathy was diagnosed age 57. At age 53 years
she had an acute encephalopathic episode associated with
aphasia, weakness of her right arm and upper motor
neuron facial palsy that persisted for days and with epi-
sodic worsening. MRI showed left sided frontotemporal
cortical edema (Figure 1). Following admission, she had
several complex partial seizures with right sided facial
twitching and rotation of the head to the right side. She
improved with lamotrigine treatment. The patient has
been started on a diet to restrict phytanic and pristanic
acid intake, however it is too early to evaluate any benefit.
Ophthalmological findings
Patient B underwent bilateral, uncomplicated cataract sur-
gery at the age of 51. She obtained good postoperativelyFigure 2 Ophthalmic features in patient B. A – C) Fundus images of the r
atrophy and moderate pigmentary retinopathy are present in the mid-periph
resembling pigmented and nonpigmentet small congenital hypertrophy of th
tomography showing a normal macula (top) but peripheral retinal pigment lavisual acuity but experienced a subjectively delayed adap-
tion to dark. At the age of 59 she had best corrected visual
acuity of 0.8 (Snellen) in both eyes. Exophoria and re-
duced convergence were noted. Slightly prominent cor-
neal nerves and keratopathy of the left eye were found on
slit lamp examination. She had pronounced bilateral aste-
roid hyalosis (Figure 2A). On ophthalmoscopy pigment
epithelial atrophy and moderate pigmentary retinopathy
was seen in the mid-periphery (Figure 2B-C).
Constricted visual fields were found on Goldmann pe-
rimetry (Figure 3). Colour vision was normal. On optical
coherence tomography peripheral retinal pigment layer
degeneration and slightly disturbed photoreceptors were
noted (Figure 2D). Full-field electroretinogram showed
normal to subnormal amplitudes of the isolated rod re-
sponse, subnormal amplitudes for the combined rod-
cone response and normal values for the 30 Hz flicker
cone response. The implicit time for the combined rod-
cone response was within normal range whereas pro-
longed values were found for the 30 Hz cone response
(Additional file 1). These findings are indicative of photo-
receptor damage.
Genetic studies
Genealogical investigation revealed that the parents of
the two siblings were consanguineous. SNP linkage sho-
wed that the two siblings shared three homozygous re-
gions comprising ~17 Mb, ~15 Mb and ~5 Mb. Based
on an assumed recessive inheritance and homozygousight eye showing pronounced asteroid hyalosis (A). Pigment epithelial
ery. The macula, optic disc and retinal vessles are normal (B). Areas
e retinal pigment epithelium were present (C). D) Optical coherence
yer degeneration and disturbances in the photoreceptor layer (bottom).
Figure 3 Goldmann perimetry in patient B. Constricted visual fields were found. In the right eye a conserved central horizontal field of
30 degrees nasally and 40 degrees temporally are seen. In the left eye the conserved visual field is 10 degrees nasally and 40 degrees temporally.
Haugarvoll et al. Orphanet Journal of Rare Diseases 2013, 8:1 Page 6 of 10
http://www.ojrd.com/content/8/1/1
Table 2 Exomic variant filtration
Filter Count
Exomic variants 19596
- Excluding synonomous variants 9584
- Not in 80 Norwegian Exomes 251
- Not in 1000Genomes (0.5% MAF) 220
Putative Recessive 7 genes
In homozygous regions shared by both siblings 3 genes
Variant filtration of exome sequencing data from Patient B compared with
whole genome genotyping data in both affected siblings reveal three genes
consistent with a homozygous causal mutation.
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tient B. This identified 19,596 genetic variants, of which
220 were not found in 80 other Norwegian exomes and
not present at > 0.5% allele frequency in the 1000 Gen-
omes database (Table 2). Analysis of these 220 rare var-
iants revealed 5 genes with homozygous variants and
two with compound heterozygous variants consistent with
autosomal recessive inheritance. Filtering using whole ge-
nome genotyping data from both affected siblings left us
with three genes - PRDM9, DROSHA, and AMACR. Ho-
mozygous AMACR gene mutations are known to cause
α-methylacyl-coA racemase deficiency, comprising peri-
pheral neuropathy, seizures and relapsing encephalopathy
with MRI findings resembling those found in our patients.
Sanger sequencing confirmed the homozygous AMACR
mutation c.367 G>A [p.Asp123Asn] (NCBI Reference se-
quence NM_014324.5) in both siblings. The diagnosis of
α-methylacyl-coA racemase deficiency was confirmed by
finding markedly increased pristanic acid levels levels in
blood in patient B (169 μmol/L, normal <1.5 μmol/L).
Radiological findings
Sequential MRI investigations were available from both
patients. These showed a specific, degeneration of cere-
bellar afferents and efferents (Figure 1). Specifically, we
found degeneration of the cerebellothalamic tract; in-
cluding prolongation of the T2 signal in the dentate nu-
cleus, atrophy and hyperintense T2-signal of the superior
cerebellar peduncle (SCP). This pattern of hyperintense
T2-signal associated with the cerebellothalamic tract can
be followed cranially to the decussation of superior cere-
bellar peduncle. There is probable prolongation of theTable 3 Metabolic profiles in peroxisomal disease
X-linked adrenoleukodystrophy
VLCFAs ↑↑
Phytanic acid -
Pristianic acid -
THCA -
DHCH -
Metabolic profiles in blood. VLCFAs = very-long-chain fatty acids, DHCA/THCA = di-T2 signal (T2 hypointensity loss) in the red nucleus. Fur-
thermore, there is hyperintense T2-signal at the level of
the superior colliculus, the posterior commissure and
the thalami indicating a chronic degeneration of both
the dentatorubral and the dentatothalamic tracts. These
findings were already present in the first MRI studies in
both patients, but progressed during the course of dis-
ease; with hyperintense T2-signal of the SCP becoming
evident in the last scan performed in patient A and grad-
ual prolongation of the T2-signal in the dentate nucleus,
i.e. development from T2-loss to hyperintense T2-signal.
Interestingly, neither of the two patients had inferior oli-
vary hypertrophy (IOH) as seen in similar lesions, when
the Guillain-Mollaret triangle is lesioned [26,27]. In
addition, there is degeneration of the cerebellar afferents
with pontine atrophy and high signal corresponding to
the transverse pontine fibers. The acute lesions corre-
sponded to encephalopatic episodes and were marked by
cortical edema and patchy restricted diffusion pattern.
Discussion
We used exome sequencing to diagnose α-methylacyl-
coA racemase deficiency in two adult siblings with a
complex autosomal recessive, adult-onset neurological
syndrome, comprising peripheral neuropathy, epilepsy,
relapsing encephalopathy, bilateral thalamic lesions on
MRI, type 2 diabetes mellitus, cataract, pigmentary retin-
opathy and tremor. A combination of homozygosity map-
ping and filtering of the exome sequencing data reduced
the number of candidate genes to three (Table 2). Re-
evaluation of the clinical phenotype and MRI images
suggested that our patients were likely to have this peroxi-
somal disorder, resulting in impaired oxidation of pristanic
acid. This diagnosis was biochemically validated by fin-
ding markedly increased pristanic acid levels in blood.
Thus, confirming that the novel, homozygous c.367 G>A
[p.Asp123Asn] AMACR mutation is pathogenic. There-
fore, no further metabolic characterization was performed
in our patients. However metabolic profiling can be used
to distinguish between different types within the heteroge-
neous group of peroxisomal diseases (Table 3) [9].
Alpha-methylacyl-coA racemase deficiency presents
heterogeneously in adults, with peripheral neuropathy, pig-
mentary retinopathy, seizures and relapsing encephalopathyRefsum disease AMACR deficiency
- -
↑↑↑ (↑)
- ↑↑↑
- ↑↑
- ↑↑
/ tri-hydroxycholestanoic acids; the bile-acid intermediates.
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in our patients, other features, including stroke-like le-
sions, peripheral neuropathy, type 2 diabetes mellitus and
thalamic MRI lesions lead us initially to suspect a mi-
tochondrial syndrome. Type 2 diabetes mellitus has not
been described in α-methylacyl-coA racemase deficiency
and may be a coincidental finding. Tremor was only ob-
served in one of our patients. These symptoms may repre-
sent rare features of this disorder. Both of our patients
had early cataract. Cataracts have previously been repor-
ted in one patient with additional retinitis pigmentosa [7].
Patient B had pigmentary changes most prominent in the
mid-periphery while the macula seemed normal. Similar
changes, also involving the right macula, were described
in her brother. Unfortunately, no fundus photos were
available for comparison. A similar retinopathy, however
predominantly in the macula, has been reported in one
patient [14]. Retinal changes have been reported in five
patients and vary from retinal pigmentary epithelial chan-
ges to retinitis pigmentosa [7,9,11,12,14].
Alpha-methylacyl-coA racemase deficiency has also
been reported in four infants although clinical presenta-
tion differed to that seen in adults with abnormal bile
acid synthesis, coagulopathy and neonatal cholestasis
[9,28,29]. In addition to the variability seen in patients
with α-methylacyl-coA racemase deficiency, deficiency
of SCPx, a downstream enzyme in the peroxisomal β-
oxidation, causes similar clinical and MRI findings with
increased pristanic acid in blood [15]. Our study shows
that, properly applied, exome sequencing has the poten-
tial to improve the diagnostic process.
Exome sequencing was originally used in the discovery
of novel genetic causes of disease [1]. It is, however, in-
creasingly being used as a diagnostic tool to replace San-
ger sequencing on a gene-by-gene basis in disorders that
display genetic heterogeneity. Exome sequencing allows
rapid screening of a large number of candidate genes
and at a cost which is no longer prohibitive, it may al-
so be a cost effective diagnostic screening tool [4]. Our
study confirms the potential of exome sequencing; how-
ever, it also highlights the difficulties associated with the
finding of a novel mutation. In our patient, the findings
allowed us to re-evaluate the clinical and MRI findings
and validate the diagnosis by biochemical measurement
of pristanic acid levels. While there are limitations to the
sensitivity of exome sequencing, including not covering
all exons and exon-intron boundaries, inconsistencies in
sequencing depth across the exome and that not all
monogenic disorders are located in the exome, [3,30] ne-
vertheless exome sequencing allows a far more complete
diagnostic evaluation than has previously been feasible.
Our MRI studies showed the combination of acute
and chronic changes. Encephalopathic episodes were as-
sociated with acute stroke-like lesions and subsequentcortical atrophy. Chronic changes, including high T2 sig-
nal in the thalami, midbrain and pons (Figure 1), were
present from the earliest stages and appear specific for
α-methylacyl-coA racemase deficiency. Both cerebellar
afferents and efferents are affected and we show that the
dentatothalamic tract is also affected (Figure 1). Gradual
progression of the chronic lesions of the cerebellar effer-
ents was also seen. The chronic MRI findings we de-
scribe have not previously been reported in detail and
appear sufficiently suggestive of this disorder to prompt
testing of blood pristanic acid levels and the early diag-
nosis of α-methylacyl-coA racemase deficiency.
Similar MRI findings have been reported in certain
mitochondrial syndromes. Long tract signal abnormal-
ities are typically seen in the syndrome of leukoencepha-
lopathy with brainstem and spinal cord involvement and
elevated lactate (LBSL). These patients also have spinal
cord changes and diffuse periventricular leukoencep-
halopathy and lack thalamic involvement [31]. Bilateral
thalamic changes and stroke-like lesions are typical of
polymerase gamma (POLG) encephalopathy, which may
also show similar clinical features [26]. With the excep-
tion of inferior olivary lesions, however, brainstem le-
sions are rare in POLG associated encephalopathy. The
combination of brainstem and thalamic lesions may oc-
cur in Leigh disease, but here the brainstem changes
affect primarily gray matter structures such as the sub-
stantia nigra, subthalamic and red nuclei and not white
matter tracts [32].
The occurrence of movement disorders in patients
with α-methylacyl-coA racemase deficiency is difficult
to evaluate. One of our patients (B) had a head tremor
(no-no), postural and action tremor of the upper limbs,
similar to essential tremor. There was no evidence of
parkinsonism or dystonia. Tremor involving the upper
limbs, head and voice has been reported previously in a
patient who also developed dysarthria [7]. An additional
patient had gait ataxia and cerebellar dysarthria [8]. One
patient with SCPx deficiency had adult onset cervical
dystonia with dystonic head tremor, cerebellar ataxia and
increased pristanic acid in blood [15]. Thus, it appears that
movement disorder, and particularly tremor, may be a part
of the disease. These patients may therefore provide im-
portant insights into movement disorders.
It is unclear how α-methylacyl-coA racemase defi-
ciency leads to pigmentary retinopathy and neuronal
death. Experimental evidence indicate that pristanic acid
may cause dramatic Ca2+ deregulation, in situ mitochon-
drial depolarization and induced generation of reactive
oxygen species (ROS) [33,34]. Importantly, a correct diag-
nosis of α-methylacyl-coA racemase deficiency may have
important implications for clinical care. Patients with
Refsum disease benefit from restricted phytanic acid in-
take and plasmapheresis [35,36]. The benefit of restricted
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racemase deficiency patients is not yet established. How-
ever, a stable clinical course has been reported in some
patients after initiation of such a diet [12]. Furthermore,
acute critical illness may lead to increased release of pris-
tanic acid stored in fat tissue, and patients may benefit
from plasmapheresis during episodes of acute illness.
Conclusions
Adult onset α-methylacyl-coA racemase (AMACR) de-
ficiency (MIM 614307) is a rare autosomal recessive
peroxisomal single enzyme deficiency disorder with ac-
cumulation of pristanic acid. Peripheral neuropathy,
pigmentary retinopathy, seizures and relapsing encephal-
opathy are common clinical features, however, the clinical
presentation is heterogeneous and patients may be mis-
labelled as possible mitochondrial disease. We used exome
sequencing to diagnose AMACR-deficiency in two sib-
lings. Furthermore we provide a detailed description of
the MRI features that may guide an early diagnosis in
these patients. Early diagnosis is pivotal, as these patients
may benefit from restricted dietary phytanic and pristanic
acid intake.
Additional file
Additional file 1: Electroretinogram (ERG) in patient B.
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